Twelve Points Wealth Management’s Vicarious Surgical RBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-512
Closed -$4.63K 180
2024
Q1
$4.63K Hold
512
﹤0.01% 173
2023
Q4
$5.63K Hold
512
﹤0.01% 164
2023
Q3
$9.07K Hold
512
﹤0.01% 170
2023
Q2
$28.1K Sell
512
-2,084
-80% -$133K 0.02% 165
2023
Q1
$177K Sell
2,596
-753
-22% -$58.5K 0.1% 158
2022
Q4
$203K Buy
3,349
+1,549
+86% +$144K 0.14% 154
2022
Q3
$181K Hold
1,800
0.14% 153
2022
Q2
$159K Buy
+1,800
New +$220K 0.12% 160

Other funds holding RBOT

Twelve Points Wealth Management's RBOT Position: Q2 2024 in Review

Twelve Points Wealth Management sold out of Vicarious Surgical (RBOT) in Q2 2024, closing a stake of 512 shares — an estimated $4.63K sold.

Twelve Points Wealth Management first reported a position in RBOT in Q2 2022 and held it in 8 quarters. The position peaked at $203K in Q4 2022. 38 funds tracked by Wall St. Rank hold RBOT as of Q2 2024.

  • Twelve Points Wealth Management reported no remaining Vicarious Surgical position as of Q2 2024 after selling out during the quarter.
  • Twelve Points Wealth Management sold 512 Vicarious Surgical shares in Q2 2024, an estimated $4.63K.
  • Twelve Points Wealth Management first reported a position in Vicarious Surgical in Q2 2022 and held it in 8 quarters.
  • Twelve Points Wealth Management's Vicarious Surgical position peaked at $203K in Q4 2022.
  • 38 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2024.

Based on Twelve Points Wealth Management's 13F filing for Q2 2024, filed 12 Jul 2024.